tirzepatide interaction with alcohol Anti-consumption agents: Tirzepatide and semaglutide for treating obesity-related diseases and Best alcohol to drink on

A retrospective cohort study of 114 patients diagnosed with prolactinomas between 2007 and 2017 was conducted

Background Glucagon-like peptide-1 receptor agonists (GLP-1RA) have cardiovascular benefits in type 2 diabetes, but none of the cardiovascular trials studied atrial fibrillation/atrial flutter (AF) as a primary endpoint

The Truth About GLP-1s: What No One Tells You with Ana Reisdorf Over 80% of people regain weight within a year after stopping GLP-1 medicationsyet few receive the guidance needed to prevent it

PlexusDx explains the science behind this side effect and how it compares to other GLP-1 therapies

Research into tirzepatide continues to expand, with ongoing trials examining its effects across a range of metabolic conditions

The finding that caught my attention: semaglutide reduced total daily insulin dose by 22.6% over 26 weeks, and the reduction appeared early, especially in bolus insulin